No Data
Jefferies Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $400
Jefferies Keeps Their Buy Rating on Madrigal Pharmaceuticals (MDGL)
Echosens Lancia Una Piattaforma Di Gestione Della Salute Epatica (LHM) a Livello Globale, Semplificando La Cura Del Fegato
Analysts Just Made A Notable Upgrade To Their Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Forecasts
Madrigal Pharmaceuticals Stock Jumps on MASH Drug Hopes
Stocks That Hedge Funds Moved From Long to Short in August - Jefferies
No Data
No Data
Market Maverick77 : what do you see from ATHA?
George Soros II Market Maverick77 : As he mentioned, unusual volumes![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Market Maverick77 George Soros II : good news?
Stock_Drift OP Market Maverick77 : I see it broke the .54 resistance.
im-him : $Trio Petroleum (TPET.US)$
View more comments...